2-(2-((4-Chlorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

Pipetas volumétricas 1 marca, clase AS, 2 ml, 12 piezas

(1R,3S,5R,7R,8aS)-7-Ethylhexahydro-1-(6-hydroxy-4-quinolinyl)-3,7-methano-1H-pyrrolo[2,1-c][1,4]oxazine>98.0%(HPLC)100mg

(S)-2-Amino-3-(2,4-dichlorophenyl)propanoic acid, 95.0%, 1g

(4-Chlorobenzyl)(methyl)sulfane, 98%, 500mg

2-Chloro-4H-pyrido[1,2-a]pyrimidin-4-one, 95.0%, 5g

Polydimethylsiloxane, trimethylsiloxy terminated 500cSt, 3kg

tert-Butyl 7-hydroxy-7,8-dihydro-4H-pyrazolo[1,5-a][1,4]diazepine-5(6H)-carboxylate, 95%, 1g

(R)-3-Amino-3-phenyl-1-propanol>97.0%(GC)200mg

METHYL 4-FLUORO-1-(TRIISOPROPYLSILANYL)-7-AZAINDOLE-5-CARBOXYLATE, 95.0%, 250mg

N,N-Dibutylformamide, 95.0%, 100ml

1-Boc-4-(4'-Cyanophenyl)piperidine, 97.0%, 100mg

tert-Butyl 3-Bromobenzoate, 98.0%, 500g